Jerry Feitelson, Ph.D. is Co-Founder/CEO of Agribody Technologies, Inc., an agricultural biotechnology company partnering with innovative seed companies. He was previously CSO of Global Clean Energy Holdings & Sustainable Oils; Manager of Business Development, IP & Alliances at Beckman Coulter; VP of Technology and Business Development at GenWay Biotech; and Research Director at Akkadix. At Mycogen, his group discovered most of the B.t. toxin genes. He was a Senior Research Microbiologist at American Cyanamid and Adjunct Professor at Rutgers University. Jerry is an inventor on 14 U.S. patents & author of 40 publications. His educational background includes a B.S in Life Sciences at MIT, a Ph.D. in Genetics with Joshua Lederberg at Stanford University School of Medicine, and an NIH postdoctoral research fellowship at the John Innes Institute, Norwich, UK in Streptomyces molecular genetics where he cloned the first gene involved in antibiotic biosynthesis with a known biochemical role.